Yes!
Activating invasion and metastasis; the drug is expected to prevent cancer cells from acquiring invasive properties
Rationale: Receptor tyrosine kinases (RTKs) are a class of receptor that can do different things – the question here stated that this one plays a key role in promoting cell motility and invasion. Inhibiting an RTK that is involved in these processes directly targets the hallmark of “Activating invasion and metastasis.”
The pathways below include a lot of proteins that come up frequently – integrins, RTKs and G-protein coupled receptors (GPCRs) activate signalling cascades including PI3K (survival), Ras (proliferation), Rho (motility), at the end of these pathways is a change are transcription factors that control gene expression.
What Next? The next cancer quiz is coming soon… but for now: here are some options!
Or try some of our other quizzes
LaNts and Laminins 